Magellan Biosciences, Inc. To Showcase Its ESA And Dynex Products For Brain Research At Neuroscience 2005 In Washington, DC, November 12-16, Booth 1928

CHELMSFORD, Mass., Nov. 3 /PRNewswire/ -- Magellan Biosciences, a leading provider of point-of-care products, automated laboratory systems, and consumables for clinical diagnostics and biomedical research, announced that it will showcase the company’s leading products for brain research in booth 1928 at Neuroscience 2005. The Society for Neuroscience’s 35th annual meeting will be held at the Washington Convention Center in Washington, DC, from November 12-16, 2005.

“ESA is a well-known name in neuroscience,” said Magellan President and CEO, Robert J. Rosenthal. “Some of the most-important discoveries in brain research have been made with ESA electrochemical detectors, which are ideal where the need for high-sensitivity analysis is of paramount importance: for example, measuring neurotransmitters and modulators such as dopamine, norephinephrine, serotonin, GABA, and acetylcholine. However, neuroscientists may be less familiar with the Dynex product lines, which use the most sophisticated detection, liquid handling, and plate-manipulation technologies to deliver the optimum combination of performance and value. Our mission at Magellan is to be recognized worldwide as a provider of innovative, high- quality products that improve outcomes from discovery to diagnostics. With the combined resources of ESA, Dynex, and Magellan, we believe we can solve additional analytical challenges for neuroscience customers.”

For neurotransmitter analysis, ESA’s HPLC systems offer the highest sensitivity available today for monoamines, amino acids, and oxidative stress- related analysis. For in vivo voltammetry, the new Cypress Systems BioStat multimode potentiostat enables real-time, in vivo measurement of nitric oxide, while the EL-400 is the benchmark for fast cyclic voltammetry. For lipid analysis, the award-winning Corona CAD lets researchers quantitate lipids using HPLC without the cost and complexity of MS.

Dynex offers a range of absorbance, fluorescence, and luminescence microplate readers and automation systems designed for the latest neurobiology applications: gene and protein expression; enzyme activity; receptor/ligand binding; ion-channel measurements; signal-transduction assays; and neural cell growth and development.

About ESA

Founded in 1968, ESA Bioscience, Inc. enables answers to the most-pressing applications challenges by delivering unique and valuable analytical systems, HPLC instruments, advanced detectors, related components and reagents, as well as services to the analytical laboratory and clinical point-of-care setting. ESA is a wholly owned subsidiary of Magellan Bioscience, Inc. For more information, visit http://www.esainc.com.

About Dynex Technologies

The experts in microplate analysis, Dynex Technologies, Inc. is a leading manufacturer of microplate instrumentation incorporating advanced detection and fully automated sample handling, consumables, and accessories used in clinical diagnostics, drug discovery, biomedical research, and industrial applications worldwide. Founded in 1952, and headquartered in Chantilly, Virginia, Dynex is a wholly owned subsidiary of Magellan Biosciences. For more information, visit http://www.dynextechnologies.com.

About Magellan Biosciences

Magellan Biosciences develops point-of-care products, related consumables, laboratory instruments, and automated systems for clinical diagnostics and biomedical research worldwide. These tools enable scientists and clinicians to produce better, more-reliable results. And improved results help drive better outcomes; a new understanding of health and disease, earlier, more-accurate diagnoses -- breakthrough discoveries that can lead to novel treatments, new cures -- innovations to enhance life. Magellan serves customers through its wholly owned subsidiaries: ESA Biosciences, Dynex Technologies, and TekCel. For more information, visit http://www.magellanbio.com.

Media Contact: Caroline A. Grossman -- 781.771.5579 -- caroline.grossman@comcast.net

Magellan Biosciences

CONTACT: Caroline A. Grossman for Magellan Biosciences, +1-781-771-5579,caroline.grossman@comcast.net

MORE ON THIS TOPIC